Sign in
CompletedNo phase

Acute and Long-term Effects of CPAP in OSA

Key facts

Who runs it
University of Zurich
Where
Switzerland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
36 people enrolled
Started
1 Feb 2021
Ended
1 Jul 2024
Type of study
Interventional
Treatments tested
  • Continuous positive airway pressure (CPAP)
Record updated
4 December 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Untreated moderate or severe OSA with an apnoea-hypopnoea-index (AHI) of ≥ 20/h and an oxygen desaturation index (>3%-dips) of ≥ 20/h in an in-laboratory sleep study
  • Epworth Sleepiness Scale Score ≥7/24 points
  • Indication for CPAP therapy
  • Written informed consent

Who cannot take part

  • Current professional driver or previous sleepiness-related accidents
  • Moderate or more severe obstructive or restrictive ventilatory disorder (FEV1 or FVC < 70%)
  • Heart failure
  • Other types of sleep-related breathing disorders, e.g. sleep-associated hypoventilation, central sleep apnoea, Cheyne Stoke's Breathing
  • Hypoxic or hypercapnic respiratory failure (awake paO2 < 9 kPa or paCO2 > 6 kPa)
  • Active treatment for OSA (CPAP, mandibular advancement device, hypoglossal nerve stimulation)
  • Pregnancy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Two-phase interventional non-inferiority trial (phase 1: at least 8 weeks of CPAP; phase 2: 2 weeks of CPAP withdrawal) including 32 patients with moderate to severe OSA to compare the physiological consequences of a short-term CPAP withdrawal to the changes in previously untreated OSA. The trial has been designed as a validation of the CPAP-withdrawal model. Baseline in-laboratory sleep studies will be performed prior to CPAP initiation, after 6-8 weeks on CPAP (treatment effect) and following 2 weeks of CPAP therapy withdrawal (withdrawal effect, effect of OSA recurrence).

The group in the trial

  • Single arm (therapy initiation followed by therapy withdrawal)Other group

    Continuous positive airway pressure (CPAP)

    Treatment: Continuous positive airway pressure (CPAP)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Acute, Intermediate and Long-term Effects of CPAP Therapy in Obstructive Sleep Apnoea: a Two-phase Interventional Trial.
Record updated
4 December 2024